January 28, 2025
Telix Completes Acquisition of RLS (USA) Inc.
MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company)…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
January 27, 2025
Clinigen expands offering with AI for pharmacovigilance
The global specialist pharmaceutical services company, Clinigen, announced on Monday a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance…
January 27, 2025
AB2 Bio in $686M Rare Disease deal with Nippon Shinyaku
AB2 Bio Ltd., a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven…
January 27, 2025
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer’s disease progression…
January 25, 2025
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for…
January 24, 2025
Moderna to supply COVID-19 vaccine in EU, Norway and North Macedonia
Moderna has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway…
January 24, 2025
Medix Biochemica buys German CANDOR Bioscience
Medix Biochemica, a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, announced the acquisition of CANDOR Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions.
January 24, 2025
Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…
January 24, 2025
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the…
January 24, 2025
Impact BioMedical Inc. to Present at The Microcap Conference
HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering,…